Cargando…
Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1
Chemotherapy is the main therapy for gastric cancer (GC) both before and after surgery, but the emergence of multidrug resistance (MDR) often leads to disease progression and recurrence. P-glycoprotein, encoded by MDR1, is a well-known multidrug efflux transporter involved in drug resistance develop...
Autores principales: | Zhang, Dongdong, Liu, Yu, Wu, Qiuwan, Zheng, Yahong, Kaweme, Natasha Mupeta, Zhang, Zhiming, Cai, Mingquan, Dong, Youhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040896/ https://www.ncbi.nlm.nih.gov/pubmed/33854595 http://dx.doi.org/10.7150/jca.53356 |
Ejemplares similares
-
Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol
por: Zhang, Dongdong, et al.
Publicado: (2021) -
Leukapheresis and Hyperleukocytosis, Past and Future
por: Zhang, Dongdong, et al.
Publicado: (2021) -
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021) -
Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development
por: Schwab, Kristopher R, et al.
Publicado: (2007) -
Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)